We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$123M
Cap. Flow
-$215M
Cap. Flow %
-7.9%
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$85.8M
2
STLD icon
Steel Dynamics
STLD
+$50.2M
3
MCK icon
McKesson
MCK
+$43.7M
4
STOR
STORE Capital Corporation
STOR
+$38.2M
5
ACGL icon
Arch Capital
ACGL
+$26M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$149M
2
DRE
Duke Realty Corp.
DRE
+$147M
3
NLSN
Nielsen Holdings plc
NLSN
+$44.3M
4
CSGP icon
CoStar Group
CSGP
+$44.2M
5
CVX icon
Chevron
CVX
+$43.8M

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Healthcare 12.35%
3 Industrials 12.24%
4 Technology 10.34%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRCA icon
1226
Verrica Pharmaceuticals
VRCA
$96.2M
$97.8K ﹤0.01%
+3,555
New +$94.9K
PTRA
1227
DELISTED
Proterra Inc. Common Stock
PTRA
$96.3K ﹤0.01%
+25,532
New +$135K
CRCT icon
1228
Cricut
CRCT
$987M
$96K ﹤0.01%
+10,353
New +$95.7K
GMDA
1229
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$95.5K ﹤0.01%
+74,032
New +$117K
OLMA icon
1230
Olema Pharmaceuticals
OLMA
$1B
$95.3K ﹤0.01%
+38,906
New +$113K
NGD
1231
DELISTED
New Gold Inc
NGD
$95.1K ﹤0.01%
+147,023
New +$148K
USX
1232
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$94.1K ﹤0.01%
51,966
-61,356
-54% -$133K
EOSE icon
1233
Eos Energy Enterprises
EOSE
$1.24B
$93.8K ﹤0.01%
63,352
+15,820
+33% +$20.5K
BMEA icon
1234
Biomea Fusion
BMEA
$91.8M
$93.6K ﹤0.01%
11,100
-41,080
-79% -$350K
QMCO icon
1235
Quantum Corp
QMCO
$441M
$93.4K ﹤0.01%
4,285
-4,593
-52% -$113K
DTIL icon
1236
Precision BioSciences
DTIL
$183M
$92.4K ﹤0.01%
+2,587
New +$102K
INDI icon
1237
indie Semiconductor
INDI
$682M
$87.5K ﹤0.01%
15,000
-800
-5% -$5.9K
IONQ icon
1238
IonQ
IONQ
$12.7B
$87K ﹤0.01%
25,204
+4
+0% +$19
KALV
1239
DELISTED
KalVista Pharmaceuticals
KALV
$87K ﹤0.01%
+12,863
New +$68.9K
OPAL icon
1240
OPAL Fuels
OPAL
$67.7M
$84.5K ﹤0.01%
+11,612
New +$93.7K
VBIV
1241
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$83.8K ﹤0.01%
7,139
+4,908
+220% +$86.6K
UWMC icon
1242
UWM Holdings
UWMC
$638M
$82.1K ﹤0.01%
24,793
– –
STXS icon
1243
Stereotaxis
STXS
$126M
$81.9K ﹤0.01%
39,570
-149,816
-79% -$293K
PBYI icon
1244
Puma Biotechnology
PBYI
$405M
$81.6K ﹤0.01%
19,300
-103,309
-84% -$356K
NBP
1245
NovaBridge Biosciences American Depositary Shares
NBP
$204M
$81.5K ﹤0.01%
+19,500
New +$73.8K
EHTH icon
1246
eHealth
EHTH
$44.1M
$79.6K ﹤0.01%
16,455
-210,331
-93% -$784K
DLTH icon
1247
Duluth Holdings
DLTH
$164M
$78.6K ﹤0.01%
+12,717
New +$95.3K
EVLV icon
1248
Evolv Technologies
EVLV
$1.01B
$78.5K ﹤0.01%
+30,300
New +$89.2K
LGF.B
1249
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$77.8K ﹤0.01%
+14,328
New +$95.1K
FBIO icon
1250
Fortress Biotech
FBIO
$110M
$77.7K ﹤0.01%
7,904
-6,685
-46% -$74K
48 49
50
51 52

Similar funds

ROC
River Oaks Capital Wayzata, Minnesota $67.9M AUM 13.58% 1-Year Est. Return
IVMX
Institutional Venture Management XIV Menlo Park, California $67.7M AUM 8.12% 1-Year Est. Return
AM
Anqa Management Sag Harbor, New York $66.5M AUM 36.45% 1-Year Est. Return
JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
FA
Financial Advantage Columbia, Maryland $65.2M AUM 14.55% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
MCMI
Matrix China Management IV Grand Cayman, Cayman Islands $64.3M AUM 53.64% 1-Year Est. Return

Ergoteles's Q4 2022 Portfolio in Review

As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.

  • Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
  • Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
  • Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
  • Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
  • Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
  • Ergoteles opened 704 new positions and closed 800 in Q4 2022.
  • Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.